These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 35069784)
21. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition. Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858 [TBL] [Abstract][Full Text] [Related]
22. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815 [TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
24. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y; Ma X; Wang Y; Li G Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting. Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1. Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245 [TBL] [Abstract][Full Text] [Related]
27. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines. Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer. Sun G; Liu M; Han H J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma. Bao L; Li X Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182 [TBL] [Abstract][Full Text] [Related]
31. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines. Chen T; Shao S; Li W; Liu Y; Cao Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3638-3648. PubMed ID: 31456425 [No Abstract] [Full Text] [Related]
32. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
33. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway. Xiao H; Zheng Y; Chen J; Shen H Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826 [TBL] [Abstract][Full Text] [Related]
34. MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway. Wang W; Zhang J; Fan Y; Zhang L Cell Cycle; 2022 Jul; 21(14):1491-1501. PubMed ID: 35416128 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5. Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C. Yao W; Jia X; Xu L; Li S; Wei L Cell Cycle; 2021 Jun; 20(12):1163-1172. PubMed ID: 34057012 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu). Gao X; Fan X; Zeng W; Liang J; Guo N; Yang X; Zhao Y Bioengineered; 2022 Mar; 13(3):7881-7893. PubMed ID: 35294329 [TBL] [Abstract][Full Text] [Related]
38. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer. Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033 [TBL] [Abstract][Full Text] [Related]
39. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis. Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467 [TBL] [Abstract][Full Text] [Related]
40. MiR-548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway. Yadollahi-Farsani M; Amini-Farsani Z; Moayedi F; Khazaei N; Yaghoobi H IUBMB Life; 2023 Feb; 75(2):97-116. PubMed ID: 36309967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]